SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Sequoia Capital is a prominent venture capital firm founded in 1972 and based in Menlo Park, California. The firm specializes in investing across various stages of startups, including seed, early, and growth stages, and focuses on sectors such as technology, healthcare, financial services, internet, and mobile. Sequoia typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $100 million in growth investments. The firm operates globally, with significant activities in regions like Israel, China, and India, where it partners with dynamic founders to build successful companies. Sequoia's extensive portfolio includes notable firms and offers valuable insights and resources, benefiting from decades of experience in the venture capital landscape.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

RA Capital Management, L.P. is a Boston-based venture capital firm focused on growth capital and early-stage investments in the healthcare and life sciences sectors. Established in 2001, the firm specializes in funding companies involved in drug development, medical devices, diagnostics, and biotechnology. It engages in a range of investment stages, from seed funding to later rounds and public offerings, often preferring to co-invest and take board positions. RA Capital targets companies that are innovating in areas such as prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The firm is staffed by professionals with backgrounds in biology, chemistry, and medicine, providing them with a deep understanding of the scientific and regulatory landscape. This expertise allows RA Capital to identify promising technologies and offer strategic guidance, including potential partnerships and insights into public market demands.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

ARCH Venture Partners, L.P. is a private equity and venture capital firm founded in 1986 and based in Chicago, Illinois, with additional offices across North America and South America. The firm specializes in early-stage and growth capital investments, primarily focusing on life sciences and biotechnology, but also covering a wide array of technology sectors such as advanced materials, communications technologies, and information technology. ARCH is recognized for its role in commercializing innovations developed at academic research institutions and national laboratories. It has raised over $3 billion through ten venture funds and has invested in more than 150 companies, often co-founding them with leading scientists and entrepreneurs. The firm typically invests between $50,000 and $150 million per company, aiming to enter at seed rounds to minimize risk, and seeks a seat on the Board of Directors for its portfolio companies. While primarily investing in the United States, ARCH also targets opportunities in Canada, Europe, and select countries in Asia, focusing on underserved geographic markets rich in scientific research and technological talent.

The Creative Destruction Lab (CDL) is a seed-stage acceleration program founded in 2012 at the Rotman School of Management in Toronto, Canada. It is dedicated to supporting massively scalable, science- and technology-based ventures by providing a unique coaching process focused on specific objectives. CDL connects startups with experienced entrepreneurs and leading scientists across various sectors, including artificial intelligence, healthcare, quantum computing, blockchain, energy, and cleantech. The program has expanded its reach, operating in six cities: Vancouver, Calgary, Toronto, Montreal, Halifax, and New York City, and emphasizes the commercialization of scientific and technological advancements.

IP Group, founded in 2001 and based in London, specializes in the commercialization of intellectual property derived from research-intensive institutions. The company focuses on identifying and developing valuable intellectual property and forming strategic commercial partnerships to maximize its potential. With a strong background in industry and finance, IP Group offers financial, strategic, and commercial expertise to its clients on an international scale. The firm has established a solid track record of delivering significant results for its portfolio companies, partners, and shareholders, particularly in sectors such as pharmaceuticals and biotechnology. Through its comprehensive approach, IP Group aims to create long-term value while fostering innovation in the marketplace.

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

Novo Holdings, established in 1999, is the holding company of the Novo Group, primarily managing the investment assets of the Novo Nordisk Foundation. Based in Copenhagen, with additional offices in San Francisco and Boston, Novo Holdings focuses on two main investment categories: Life Science Investments, which encompasses funding life science companies at various stages of development, and Financial Investments, which entails managing a diversified portfolio of equity and fixed income securities. As a prominent life science investor, Novo Holdings aims to create long-term value while ensuring that the Foundation can distribute returns for scientific, social, and humanitarian purposes to enhance public health and welfare. The company has also developed initiatives such as Novo Seeds, which supports early-stage applied research in life sciences, and invests in later-stage life science companies through growth equity. Novo Holdings maintains a strategic influence over affiliated companies, aligning their operations with the values and objectives of the Novo Group.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

Lilly Asia Ventures, established in 2008 and based in Shanghai, China, serves as the corporate venture capital arm of Eli Lilly and Company. The firm focuses on making investments in the life sciences and healthcare sectors, primarily targeting opportunities in China but also considering ventures in other parts of East and South Asia. Lilly Asia Ventures seeks to invest in companies at various stages, from seed to later stages, with a preference for those showcasing strong management teams and innovative technologies or business models. The investment strategy emphasizes human therapeutics, medical technology, healthcare services, and broader life sciences. Typically, investments range from $5 million to $15 million per round, with an inclination towards acquiring minority stakes, usually under 20 percent. The firm aims to play an active role in its portfolio companies by seeking board seats or observation rights.

Parkwalk Advisors Ltd is a London-based venture capital firm that specializes in investing in technology companies, particularly those spun out of UK universities. Founded in 2009, the firm focuses on growth capital opportunities across various stages, including seed, early, mid, and late venture funding. Parkwalk primarily targets sectors such as healthcare, energy, materials, and digital technologies, with a preference for companies that possess intellectual property and operational freedom. The firm typically invests between £250,000 and £10 million, aiming to generate capital gains for investors while benefiting from tax relief incentives. Parkwalk leverages extensive networks in academia and technology transfer to access high-quality investment opportunities. In 2017, it became a subsidiary of IP Group Plc, enhancing its capabilities in intellectual property commercialization.

The Bill & Melinda Gates Foundation is a prominent grant-making organization co-founded by Bill and Melinda Gates in 2000, headquartered in Seattle, Washington, with additional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. The foundation focuses on improving global health, enhancing education, and providing support to at-risk families, particularly in the Pacific Northwest. It actively promotes strategies that assist low-income families and works towards greater equality in various sectors. The foundation is also involved in investment management, overseeing an endowment that includes a diverse portfolio primarily in public equity and fixed income markets, while excluding tobacco-related investments. Its trustees include Bill Gates, Melinda Gates, and Warren Buffett.

M Ventures is an early-stage venture capital firm based in Los Angeles, California, established in 2017. The firm focuses on direct investments in technology companies, particularly those aligned with emerging cultural trends and behaviors in a diverse global marketplace. M Ventures aims to identify innovative ideas, technologies, and products that have the potential to become widely influential. Its investment strategy emphasizes early venture opportunities, seeking to support companies that can leverage shifts in consumer dynamics and technological advancements. Through its strategic approach, M Ventures actively contributes to the growth and success of its portfolio companies.

Mitsubishi UFJ Capital Co., Ltd. is a Tokyo-based venture capital firm established in 1974, specializing in seed, development stage, and start-up investments. The firm focuses primarily on the Japanese market, investing in sectors such as healthcare, biotechnology, information technology, electronics, and high technology. Mitsubishi UFJ Capital actively participates in investment syndications for Japanese investments and aims to support companies with relevance to the Japanese market. The firm operates additional offices in Osaka and Nagoya, enhancing its reach within Japan. It manages several venture capital funds, including those targeting drug discovery and life sciences.

High-Tech Gründerfonds Management GmbH, established in 2005 and based in Bonn, Germany, is a venture capital firm that specializes in early-stage investments in high-tech startups across various sectors, including information and communication technology, software, healthcare, and life sciences. The firm focuses on companies that are less than one year old and have a turnover of less than €10 million. High-Tech Gründerfonds typically invests between €0.5 million and €3 million, acquiring a minority stake of up to 25% in its portfolio companies. The firm often acts as the lead investor and provides follow-on financing, having facilitated over €2 billion in additional funding from external investors. With a commitment to nurturing innovation, it has supported the development of more than 500 startups and has successfully exited over 100 investments. The firm’s backing includes participation from various public and private entities, reflecting its role as a key player in the German startup ecosystem.

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With a focus on technology and healthcare sectors, Polaris invests in companies at all stages of development, from inception to profitable growth. The firm has a history of partnering with experienced entrepreneurs and innovators, aiming to enhance the way people live and work. In addition to its Boston headquarters, Polaris has offices in San Francisco and New York, and it actively targets investments in life sciences, biotechnology, and software industries across the United States and Europe. Over its more than two-decade history, Polaris Partners has established itself as a multibillion-dollar investment firm committed to fostering innovation and entrepreneurship.

Plug and Play, founded in 2006 and based in Sunnyvale, California, operates as a business accelerator and venture capital firm that focuses on early-stage and seed investments in technology startups. The firm runs 12 industry-specific accelerator programs annually, connecting startups with corporate partners and investors to foster collaboration and growth. Plug and Play's investment strategy encompasses a wide range of sectors, including fintech, health and wellness, travel, cybersecurity, and sustainability, allowing it to support diverse startups from any country. The firm provides various resources, including funding, mentorship, office space, and networking opportunities, and has a global presence with offices in North America, Europe, and Asia. Plug and Play has a strong track record, having helped numerous startups secure over $9 billion in funding since its inception. Its programs aim to refine business models and facilitate introductions to potential investors, ultimately contributing to the growth of the startup ecosystem.

Shenzhen Capital Group Co., Ltd is a venture capital firm established by the Shenzhen Government in 1999. The company aims to cultivate national industries, promote economic transformation, and support emerging industries. With a registered capital of 5.42 billion RMB and total assets under management of 338.99 billion RMB, the firm primarily invests in small and medium-sized enterprises (SMEs), innovative high-tech companies, and businesses in various stages of growth and transformation. Its investment focus spans sectors aligned with national policies, including information technology, new media, biopharma, new energy, environmental protection, and high-end equipment manufacturing. By April 2019, Shenzhen Capital Group had built a diverse portfolio of 994 companies, with investments totaling 43.9 billion RMB, and had successfully listed 145 of these companies across 16 global capital markets.

5AM Ventures is a venture capital firm founded in 2002 and headquartered in San Francisco, California, with an additional office in Boston. The firm specializes in seed- and early-stage investments, focusing on companies within the life sciences, healthcare, and technology sectors. Its investment portfolio includes firms involved in biopharmaceuticals, medical technology, drug delivery technologies, and research instruments. 5AM Ventures is recognized for its commitment to fostering innovation in advanced life science technologies.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.

Intel Corporation is a leading global designer and manufacturer of semiconductor technologies, focused on powering the cloud, smart devices, and connected technologies. Founded in 1968 and headquartered in Santa Clara, California, Intel operates through various segments including Data Center Group, Internet of Things Group, Mobileye, and Client Computing Group, among others. The company offers a range of products such as central processing units, chipsets, accelerators, and memory solutions, catering to original equipment manufacturers, original design manufacturers, and cloud service providers. Intel has been transitioning from a PC-centric to a data-centric business model, emphasizing advancements in performance, power, and connectivity across various workloads. With a strong commitment to innovation, Intel also invests through Intel Capital in startups that drive technologies in cloud infrastructure, artificial intelligence, and 5G, among others. The company’s collaborations with prominent organizations aim to develop privacy-preserving analytics and enhance computing capabilities. As one of the largest semiconductor manufacturers by revenue, Intel continues to shape the future of computing and communications.

Future Planet Capital is a venture capital firm founded in 2016 and based in London, United Kingdom. The firm specializes in capital growth and invests across various stages, including seed, early, mid, and late venture stages, as well as fund of funds investments. It focuses on companies that aim to commercialize research from UK universities, particularly in sectors addressing climate change, education, healthcare, security, and sustainable growth. By connecting large investors with innovative solutions, Future Planet Capital seeks to profitably tackle some of the world's most pressing challenges while supporting the development of breakthrough technologies.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that focuses on fostering the development and adoption of new technologies in the region. For over 30 years, it has served as a key provider of seed-stage capital, investing more than $170 million in over 1,750 regional technology companies, many of which have achieved industry leadership. In addition to financial support, Ben Franklin promotes university and industry partnerships that facilitate the commercialization of scientific discoveries. The organization is dedicated to strengthening the entrepreneurial ecosystem in Southeastern Pennsylvania, thereby creating jobs and enhancing the technology community.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. As the strategic investment arm of Alexandria Real Estate Equities, it focuses on providing capital to seed, early-stage, and growth-stage companies within the healthcare sector. The firm emphasizes investments in biopharma, diagnostics, life sciences, research tools, agrifoodtech, and agtech. Alexandria Venture Investments aims to support innovative entities developing breakthrough technologies and therapies, leveraging its extensive industry knowledge and relationships with leading investors. Its approach is characterized by a commitment to fostering innovation and entrepreneurship in the life sciences and technology sectors.

SMBC Venture Capital Co., Ltd. is the private equity and venture capital division of Sumitomo Mitsui Banking Corporation, focusing on growth capital and buyout investments. Established in 2005 and headquartered in Tokyo, with an additional office in Osaka, the firm invests across various sectors, including information technology, life sciences, services, and manufacturing. By leveraging its parent company's extensive financial services background, SMBC Venture Capital aims to support the development of innovative companies and foster growth within diverse industries.

Andreessen Horowitz LLC, founded in 2009 by Marc Andreessen and Ben Horowitz, is a venture capital firm based in Menlo Park, California. The firm specializes in investing across various stages of company development, from seed and early-stage to growth and late-stage ventures. It primarily targets the technology sector, with a strong emphasis on software, cloud computing, and Internet infrastructure. The firm also explores opportunities in consumer and business Internet applications, mobile software, and data storage, as well as at the intersection of computer science and life sciences, particularly in areas like digital therapeutics and computational medicine. Andreessen Horowitz is known for its significant financial backing, with investments typically ranging from $50,000 to $50 million. The firm has established multiple funds, including early-stage funds that focus on a variety of sectors, while explicitly avoiding investments in clean energy, transportation, and certain life sciences domains.

Legend Capital, founded in 2001 as a subsidiary of Legend Holdings Ltd., is a prominent asset manager based in China. With a focus on private equity investments, the firm manages approximately $700 million across four funds and specializes in early-stage and mid-market growth ventures. Its investment strategy primarily targets high-growth companies with significant operations in China or related markets, particularly in sectors such as information technology, consumer goods, clean technology, healthcare, and equipment manufacturing. Legend Capital is known for its active involvement with portfolio companies, providing comprehensive business resources and tailored services to enhance business development and company visibility in the Chinese market. The firm’s portfolio includes notable companies like Joyo.com, SinoCom, and Solarfun Power, reflecting its commitment to driving innovation and value creation within China's venture capital landscape.

Scottish Enterprise is Scotland's primary economic development agency, operating as a non-departmental public body under the Scottish Government. Established in 1991 and based in Glasgow, it aims to foster an innovative and productive economy by partnering with both public and private sectors to identify and capitalize on high-value opportunities. The organization supports small and medium-sized enterprises (SMEs) by helping them secure necessary financing, enhancing management capabilities, and facilitating growth. Through its arm, the Scottish Investment Bank, it engages in direct and fund of fund investments, focusing on sectors such as renewable energy, healthcare, technology, and creative industries. It typically invests between £0.01 million and £10 million, utilizing various financial instruments including loans, equity, and mezzanine financing. Scottish Enterprise also collaborates with UK and international investors, including business angels and venture capital groups, to stimulate the funding market in Scotland and enhance the growth potential of Scottish businesses.

In-Q-Tel, founded in 1999 and based in Tysons, Virginia, is a not-for-profit venture capital firm that partners with innovative companies to provide advanced technologies to the U.S. Intelligence Community, including the Central Intelligence Agency. The organization focuses on accelerating the development and delivery of vital solutions that enhance national security. In-Q-Tel invests in a diverse range of technology sectors, such as artificial intelligence, biotechnology, data analytics, and the Internet of Things, seeking to support startups that can deliver timely innovations essential for intelligence and defense operations. By identifying and fostering cutting-edge technology, In-Q-Tel plays a crucial role in equipping government agencies with the tools necessary to fulfill their missions effectively.

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

Sofinnova Partners is an independent venture capital firm headquartered in Paris, France, with a focus on the life sciences sector, including biopharmaceuticals, biotechnology, medical devices, and industrial biotechnology. Over its 45-year history, the firm has financed nearly 500 companies, primarily targeting start-ups, early-stage ventures, corporate spin-offs, and occasional turnaround situations. Sofinnova Partners actively sources investment opportunities and often serves as the first institutional investor in Series A financings, taking a lead role in its portfolio companies. The firm engages closely with entrepreneurs from the formation phase, holding board positions and guiding companies through their development until exit. While primarily investing throughout Europe, Sofinnova Partners also allocates a portion of its investments globally.

Par Equity LLP is a venture capital and private equity firm based in Edinburgh, Scotland, specializing in early-stage investments and growth opportunities in small to medium-sized enterprises (SMEs) with high growth potential. Founded in 2008, the firm primarily targets companies within the technology sector, including digital health technology, and focuses on those that possess proprietary technology or proven commercial products poised for transatlantic expansion. Par Equity seeks to invest in Scottish companies aiming to enter the United States market and vice versa, while also considering opportunities in the North of England and Northern Ireland. The firm typically invests between £0.25 million and £2.5 million in companies with enterprise values up to £10 million. Par Equity utilizes government-approved tax wrappers to enhance returns for its investors and operates an additional office in San Francisco, California.

Johnson & Johnson Innovation - JJDC, established in 1973 and based in New Brunswick, New Jersey, serves as the corporate venture capital arm of Johnson & Johnson. The organization focuses on identifying transformative ideas and nurturing them into viable solutions for patients. JJDC targets investments in companies within the pharmaceuticals, medical devices, consumer healthcare, and medtech sectors, aiming to foster innovation that addresses current healthcare challenges. By supporting emerging companies, JJDC plays a crucial role in advancing healthcare solutions and enhancing patient outcomes.

Samsung Ventures, founded in 1999 and headquartered in Seoul, South Korea, is a venture investment firm focused on discovering and developing innovative businesses and technologies. The firm specializes in sourcing, qualifying, and investing in technology-related companies, with a portfolio that spans various sectors including semiconductors, mobile services, software, cybersecurity, and bioengineering. Samsung Ventures manages over $1.8 billion in assets and allocates approximately $250 million annually to support early-stage startups and pre-IPO companies. With a presence in major global innovation hubs such as the San Francisco Bay Area, Boston, London, and Tokyo, the firm seeks to back emerging technology entrepreneurs who are expected to shape the future. Areas of interest include artificial intelligence, robotics, augmented and virtual reality, 5G technology, and digital health, among others.

Pfizer is one of the largest pharmaceutical companies in the world, founded in 1849 and headquartered in the United States. The company is dedicated to improving health and well-being by applying scientific advancements and global resources. Pfizer manufactures and sells a diverse range of healthcare products, primarily focusing on prescription drugs and vaccines, which account for the majority of its sales. Notable products include the pneumococcal vaccine Prevnar 13, the cancer treatment Ibrance, and the cardiovascular drug Eliquis. With annual sales nearing $50 billion, Pfizer has a strong international presence, with nearly half of its sales derived from global markets, particularly emerging economies. The firm is committed to providing access to safe, effective, and affordable medicines to enhance patient outcomes and address pressing healthcare challenges.

Hillhouse Investment Management, Ltd. is a private equity firm founded in 2005 by Zhang Lei, with a focus on long-term investments across various stages, from seed funding to buyouts and public equities. The firm operates globally, emphasizing opportunities in Asia, and invests primarily in sectors such as consumer goods, technology, media, telecommunications, healthcare, and advanced manufacturing. In the healthcare space, Hillhouse particularly targets biotechnology, medical devices, and pharmaceuticals. Its investment strategy is characterized by a stage-agnostic approach, allowing for continued investment in companies as they progress from startups to established public entities. Hillhouse is headquartered in Central, Hong Kong, with additional offices in Beijing and New York, and operates as a subsidiary of Hillhouse Capital Group Limited.

work with private equity and venture capital fund managers, investment advisors and business entities from around the world.

Northern Light Venture Capital, founded in 2005 by Feng Deng and Yan Ke, is a China-focused venture capital firm that manages approximately $1.5 billion in committed capital across multiple funds. With a team of five Managing Directors, it has invested in over 180 portfolio companies, primarily targeting early and growth stage opportunities in sectors such as information technology, new media, clean technologies, consumer services, and healthcare. The firm is distinguished by its partnership of experienced local Chinese and returnee executives, who have significant backgrounds in investing and entrepreneurship. Notable portfolio companies include Meituan.com, Kaixin001.com, and Gogo.com. Northern Light Venture Capital aims to leverage China's industrial and economic resources to foster innovative and disruptive business ventures that can thrive in the global market.

F Prime, Inc. is a venture capital firm based in Cambridge, Massachusetts, with additional offices in San Francisco and London. Founded in 1969, it is part of the legacy of Fidelity Investments, one of the largest asset management firms in the world. F Prime focuses on investing in North American and European companies across various sectors, including healthcare, life sciences, medtech, technology, and health information technology. The firm operates several specialized funds, such as those dedicated to healthcare and life sciences, which aim to support early-stage companies in these industries. With a commitment to fostering entrepreneurship, F Prime leverages its extensive insights, domain expertise, and relationships to assist entrepreneurs in building impactful companies, all while avoiding the pressures of external fundraising.

Almi Invest is a Swedish venture capital firm established in 2009, focusing on investing in promising start-ups with scalable business models and committed entrepreneurs. The firm operates through seven regionally based funds, each managed by experienced local investment professionals. With a total capital of SEK 1 billion, Almi Invest typically makes initial investments ranging from SEK 2 to 4 million, with the potential to extend up to SEK 10 million during the investment's lifecycle. The firm emphasizes collaboration by syndicating investments with other venture capitalists or angel investors, allowing it to acquire a maximum of 50 percent of shares in any given funding round. Almi Invest sources its capital from European Union structural funds and regional investors, with half of its funding derived from each. The firm's structure as an Evergreen Fund allows it to reinvest generated returns, contributing to its ongoing investment capacity. Additionally, the Almi Invest GreenTech Fund targets early-stage investments in clean tech, climate tech, and life sciences, aiming for a diverse portfolio through at least 50 investments.

Casdin Capital, LLC is an investment firm specializing in the life sciences and healthcare sectors. Founded in 2012 by Eli Casdin, who serves as the Chief Investment Officer, the firm employs a fundamental research approach to manage a long-short equity fund. Casdin Capital invests across a spectrum of opportunities, ranging from early-stage to late-stage private investments. As of October 2020, the firm manages approximately $2.2 billion in assets.

Quantonation is a venture capital fund based in Paris, France, that focuses exclusively on investments in quantum and quantum-enabling technologies. It aims to support the development of innovative applications in areas such as computation, communications, simulation, and sensing. Established in 2021, Quantonation targets early-stage startups and typically invests between EUR 0.25 million and EUR 2 million per project. The fund seeks to make approximately 15 to 20 investments, primarily in North America, Asia, the Middle East, and Europe, fostering advancements in both hardware and software related to quantum technologies.

Global Brain is a Tokyo-based venture capital firm founded in 1998, specializing in early-stage investments across various sectors, including e-commerce, software, gaming, media, IoT, education, entertainment, and fintech. The firm has expanded its investment activities to the US and Asia, targeting series A-stage technology companies. Since its inception, Global Brain has invested in approximately 30 companies, achieving seven initial public offerings and seven mergers and acquisitions. The firm supports its portfolio companies by providing not only capital but also strategic guidance, partnerships, and team-building resources to help them reach their milestones. Global Brain is particularly adept in e-commerce, operating a platform called EC-PLANET, which encompasses several group companies, including a large online sports goods store and a logistics firm offering comprehensive fulfillment services. This network, along with Global Brain's connections to established Japanese companies, facilitates market entry for US and Asian businesses into Japan.

Innovation Industries is a Netherlands-based venture capital firm established in 2017, specializing in early-stage investments in high-tech, med-tech, and agri-food tech companies. The firm adopts a hands-on management approach, offering entrepreneurs not only financial support but also valuable expertise, industry knowledge, and connections to enhance their ventures. By actively assisting portfolio companies, Innovation Industries aims to strengthen their value propositions, accelerate their time-to-market, and facilitate strategic partnerships while helping them navigate common start-up challenges. Although the firm primarily focuses on start-ups, it also invests in scale-ups, ensuring a broad spectrum of funding capabilities. This approach allows Innovation Industries to sustain emerging breakthroughs in research and technology with sufficient venture capital, ultimately optimizing the companies' chances of success and delivering returns to its investors as these businesses grow and develop.